Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent

Blood Res. 2015 Jun;50(2):113-4. doi: 10.5045/br.2015.50.2.113. Epub 2015 Jun 25.
No abstract available